Atrium Health Oral Medicine & Maxillofacial Surgery
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Villa, Alessandro
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
AQUAX2, NCT05926765: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Recruiting
2
120
Europe, Canada, US
AAV2-hAQP1 Concentration 1, AAV2-hAQP1 Concentration 2, Placebo
MeiraGTx, LLC
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
07/25
07/25
NCT03972527: Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Completed
N/A
85
US
Photobiomodulation, low-level laser therapy, Routine Oral Care and Analgesia, Pain medication, oral rinses
MuReva Phototherapy Inc.
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Head and Neck Cancer
06/24
07/24
Natalya
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
Novo, Nolan
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
Hendron, Wilfred
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Villa, Alessandro
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
AQUAX2, NCT05926765: A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Recruiting
2
120
Europe, Canada, US
AAV2-hAQP1 Concentration 1, AAV2-hAQP1 Concentration 2, Placebo
MeiraGTx, LLC
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
07/25
07/25
NCT03972527: Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Completed
N/A
85
US
Photobiomodulation, low-level laser therapy, Routine Oral Care and Analgesia, Pain medication, oral rinses
MuReva Phototherapy Inc.
Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy, Head and Neck Cancer
06/24
07/24
Natalya
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
Novo, Nolan
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26
Hendron, Wilfred
NCT06233591: Evaluating LP-10 in Subjects With OLP

Recruiting
2
24
US
LP-10 (Liposomal Tacrolimus)
Lipella Pharmaceuticals, Inc.
Oral Lichen Planus
09/25
03/26

Download Options